Glycopyrronium
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Glycopyrronium and local guidelines before prescribing.
Antimuscarinic
Mechanism
Quaternary antimuscarinic.
Uses
COPD (inhaled), excessive drooling and secretions, premedication.
Dosing
- Symptomatic: Pyridostigmine 30–60 mg 4–6 times daily. Side effects: diarrhoea, cramps, sweating, salivation (glycopyrronium or propantheline help). Too much causes a cholinergic crisis (weakness, secretions).
Neurology: Neuromuscular disease - Respiratory secretions | Glycopyrronium 200 micrograms SC 4-hourly, or hyoscine butylbromide 20 mg SC hourly to 4-hourly (maximum 120 mg in 24 hours)
Palliative: End of Life Care - Glycopyrronium SC 200 micrograms 4-hourly | Respiratory secretions; doesn't cross into the brain (no sedation).
Palliative: End of Life Care
Side effects
Dry mouth, urinary retention, tachycardia, constipation, blurred vision.
Interactions
Other antimuscarinics additive.
Contraindications and cautions
Narrow-angle glaucoma, myasthenia gravis, urinary retention
Monitoring
Heart rate, urine output
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Caution in glaucoma and urinary retention.
More from the textbook: uses, cautions and other points
- LAMA - tiotropium , umeclidinium, glycopyrronium, aclidinium - once or twice daily; mainly COPD; also add-on in severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - Triple therapy (LABA + LAMA + ICS in one inhaler - e.g. fluticasone furoate–umeclidinium–vilanterol, beclometasone–formoterol–glycopyrronium) - COPD with continued exacerbations (especially with raised eosinophils or asthmatic features); severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - Rocuronium , atracurium (non-depolarising) - reversed by neostigmine (with glycopyrronium) or sugammadex (rocuronium and vecuronium); people with myasthenia are very sensitive to them.
Neurology: Anatomy, Physiology and Pharmacology - Non-motor symptoms - Parkinson's psychosis (reduce drugs in reverse order of benefit; quetiapine or clozapine - clozapine needs blood monitoring); dementia ( rivastigmine ); depression; constipation; postural hypotension (fludrocortisone, midodrine); drooling (glycopyrronium).
Neurology: Anatomy, Physiology and Pharmacology - Drooling: Speech therapy; glycopyrronium ; botulinum toxin to the salivary glands.
Neurology: Movement Disorders - Drooling - glycopyrronium, amitriptyline, hyoscine patches, botulinum toxin.
Neurology: Neuromuscular disease
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Neuromuscular disease (3 mentions)
- Palliative: End of Life Care (8 mentions)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- ENT: Neck lumps and cancer (1 mention)
- Medicine of the older adult. Discharge, capacity, advance care planning and end of life (2 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (4 mentions)
- Anaesthesia: Perioperative care, pain and anaesthetic complications (1 mention)
- Integrated paediatrics chapter (2 mentions)
- General Practice: Mental health, safeguarding, certification and the law (1 mention)